secwatch / observer
8-K filed April 19, 2023, 7:59 PM ET ticker ABT CIK 0000001800
earnings confidence high sentiment positive materiality 0.75

Abbott Q1 revenue $9.7B, adj EPS $1.03; base business organic growth 10.0%

ABBOTT LABORATORIES

2023-Q1 EPS reported $0.75 revenue$9,747,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ABBOTT LABORATORIES reported first quarter ended March 31, 2023 results: revenue $9.7 billion, EPS First-quarter GAAP diluted EPS of $0.75 and adjusted diluted EPS of $1.03. Guidance reaffirmed.

Period
first quarter ended March 31, 2023
Revenue
$9.7 billion
EPS
First-quarter GAAP diluted EPS of $0.75 and adjusted diluted EPS of $1.03
Guidance
reaffirmed
Result
reported results
Exact text from the filing
in accordance with GAAP. --- EX-99.1 (EX-99.1) --- 9.1 News Release Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business – Sales of $9.7 billion driven by strong underlying base business performance – Reported sales decreased 18.1 percent due to anticipated decline in COVID-19 testing-related sales versus prior year –
View on SEC.gov

Browse all earnings releases →

ABBOTT LABORATORIES filing history →

Source: SEC EDGAR
accession 0001628280-23-012020
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.